Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Inventory Average (2016 - 2025)

Vanda Pharmaceuticals' Inventory Average history spans 13 years, with the latest figure at $1.9 million for Q4 2025.

  • For Q4 2025, Inventory Average rose 16.59% year-over-year to $1.9 million; the TTM value through Dec 2025 reached $1.9 million, up 16.59%, while the annual FY2025 figure was $1.8 million, 70.01% down from the prior year.
  • Inventory Average for Q4 2025 was $1.9 million at Vanda Pharmaceuticals, down from $2.1 million in the prior quarter.
  • Across five years, Inventory Average topped out at $10.4 million in Q2 2023 and bottomed at $978500.0 in Q3 2021.
  • The 5-year median for Inventory Average is $4.1 million (2021), against an average of $3.9 million.
  • The largest annual shift saw Inventory Average surged 471.69% in 2022 before it crashed 85.75% in 2024.
  • A 5-year view of Inventory Average shows it stood at $4.6 million in 2021, then tumbled by 69.59% to $1.4 million in 2022, then skyrocketed by 302.69% to $5.6 million in 2023, then crashed by 70.21% to $1.7 million in 2024, then grew by 16.59% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for VNDA's Inventory Average are $1.9 million (Q4 2025), $2.1 million (Q3 2025), and $2.0 million (Q2 2025).